SCHEMBL513484

SCHEMBL513484

CCc1cc(C)c(Br)c(CC)c1-c1c(O)c(C)nn(C)c1=O

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.30
MAPK8 P45983 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL513844 0.91 MAPK8 (0.30) MAPK8
SCHEMBL513255 0.85 CASR (0.32) HPGD
SCHEMBL513333 0.84 KDM4E (0.31) HPGDMAPK8
SCHEMBL514400 0.82 MMP1 (0.31)
SCHEMBL514980 0.81 PDE4A (0.31)
SCHEMBL512973 0.81 CASR (0.33)
SCHEMBL18131563 0.81 CDK8 (0.34) HPGD
SCHEMBL466412 0.80 MAPT (0.36) HPGD
SCHEMBL513374 0.79 NPC1 (0.39) HPGDMAPK8
SCHEMBL16642353 0.79 CRHR1 (0.38) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028988-A1 USE OF PYRIDAZINONE COMPOUND FOR CONTROL OF HARMFUL ARTHROPOD PESTS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028988-A1 USE OF PYRIDAZINONE COMPOUND FOR CONTROL OF HARMFUL ARTHROPOD PESTS PLPBP, PNPO, PIR HPGD 733/4885MAPK8 1680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.